Your browser doesn't support javascript.
loading
[Research progress in targeting autophagy of traditional Chinese medicine and natural compounds to regulate atherosclerosis].
Zhou, Man-Li; Yu, Yun-Feng; Zhao, Yan-Zhen; Luo, Xiao-Xin; Zhu, Jia-le; Hu, Yi-Lei; Jian, Wei-Xiong.
Afiliação
  • Zhou ML; School of Traditional Chinese Medicine, Hunan University of Chinese Medicine Changsha 410208, China.
  • Yu YF; School of Traditional Chinese Medicine, Hunan University of Chinese Medicine Changsha 410208, China.
  • Zhao YZ; School of Traditional Chinese Medicine, Hunan University of Chinese Medicine Changsha 410208, China.
  • Luo XX; School of Traditional Chinese Medicine, Hunan University of Chinese Medicine Changsha 410208, China.
  • Zhu JL; School of Traditional Chinese Medicine, Hunan University of Chinese Medicine Changsha 410208, China.
  • Hu YL; School of Traditional Chinese Medicine, Hunan University of Chinese Medicine Changsha 410208, China.
  • Jian WX; School of Traditional Chinese Medicine, Hunan University of Chinese Medicine Changsha 410208, China Hunan Provincial Key Laboratory of National Key Discipline of Traditional Chinese Medicine Diagnostics,Hunan University of Chinese Medicine Changsha 410208, China.
Zhongguo Zhong Yao Za Zhi ; 48(2): 311-320, 2023 Jan.
Article em Zh | MEDLINE | ID: mdl-36725220
Atherosclerosis(AS) is the common pathological basis of many ischemic cardiovascular diseases, and its formation process involves various aspects such as vascular endothelial injury and platelet activation. Vascular endothelial injury is the initiating factor of AS plaque. Monocytes are recruited to differentiate into macrophages at the damaged endothelial cells, which absorb oxidized low-density lipoprotein(ox-LDL) and slowly transform into foam cells. Smooth muscle cells(SMCs) proliferate and migrate continuously. As the only cell producing interstitial collagen fibers in the fibrous cap, SMCs largely determine whether the plaque ruptured or not. The amplifying inflammatory response during the formation of AS recruits platelets to adhere to the damaged area of vascular endothelium and stimulates excessive platelet aggregation. Autophagy activity is associated with vascular lesions and abnormal platelet activation, and excessive autophagy is considered to be a negative factor for plaque stability. Therefore, precise regulation of different types of vascular autophagy and platelet autophagy to treat AS may provide a new therapeutic perspective for the prevention and treatment of atherosclerotic ischemic cardiovascular disease. Currently, treatment strategies for AS still focus on lowering lipid levels with high-intensity statins, which often cause significant side effects. Therefore, the development of safer and more effective drugs and treatment modes is the focus of current research. Traditional Chinese medicine and natural compounds have the potential to treat AS by targeted autophagy, and have been playing an increasingly important role in the prevention and treatment of cardiovascular diseases in China. This paper summarizes the experimental studies on different vascular cell types and platelet autophagy in AS, and sums up the published research results on targeted autophagy of traditional Chinese medicine and natural plant compounds to regulate AS, providing new ideas for further research.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Aterosclerose / Placa Aterosclerótica Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: Zh Revista: Zhongguo Zhong Yao Za Zhi Assunto da revista: FARMACOLOGIA / TERAPIAS COMPLEMENTARES Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Aterosclerose / Placa Aterosclerótica Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: Zh Revista: Zhongguo Zhong Yao Za Zhi Assunto da revista: FARMACOLOGIA / TERAPIAS COMPLEMENTARES Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China